Schizophrenia Research
Volume 112, Issue 1 , Pages 54-64 , July 2009

Subcortical oligodendrocyte- and astrocyte-associated gene expression in subjects with schizophrenia, major depression and bipolar disorder

  • Kevin Barley

      Affiliations

    • J.J. Peters Department of Veterans Affairs Medical Center, 130 West Kingsbridge Ave., Bronx, New York, 10468, United States
    • Department of Psychiatry, Mount Sinai School of Medicine, One Gustave Levy Place, New York, NY 10029, United States
    • ,
  • Stella Dracheva

      Affiliations

    • J.J. Peters Department of Veterans Affairs Medical Center, 130 West Kingsbridge Ave., Bronx, New York, 10468, United States
    • Department of Psychiatry, Mount Sinai School of Medicine, One Gustave Levy Place, New York, NY 10029, United States
    • ,
  • William Byne

      Affiliations

    • J.J. Peters Department of Veterans Affairs Medical Center, 130 West Kingsbridge Ave., Bronx, New York, 10468, United States
    • Department of Psychiatry, Mount Sinai School of Medicine, One Gustave Levy Place, New York, NY 10029, United States
    • Corresponding Author InformationCorresponding author. Research Bldg. Room 2F39, JJ Peters VA Medical Center, 130 West Kingsbridge Road, Bronx, NY 10468, United States.

Received 19 February 2009 ,Revised 7 April 2009 ,Accepted 9 April 2009.

References 

  1. Ardekani BA, Nierenberg J, Hoptman MJ, Javitt DC, Lim KO. MRI study of white matter diffusion anisotropy in schizophrenia. Neuroreport. 2003;14:2025–2029
  2. Anderson CM, Swanson RA. Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia. 2000;32:1–14
  3. Aston C, Jiang L, Sokolov BP. Microarray analysis of postmortem temporal cortex from patients with schizophrenia. J. Neurosci. Res. 2004;77:858–866
  4. Aston C, Jiang L, Sokolov BP. Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Mol. Psychiatry. 2005;10:309–322
  5. Awatramani R, Scherer S, Grinspan J, Collarini E, Skoff R, O'Hagan D, et al. Evidence that the homeodomain protein Gtx is involved in the regulation of oligodendrocyte myelination. J. Neurosci. 1997;17:6657–6668
  6. Ballmaier M, Schlagenhauf F, Toga AW, Gallinat J, Koslowski M, Zoli M, et al. Regional patterns and clinical correlates of basal ganglia morphology in non-medicated schizophrenia. Schizophr. Res. 2008;106:140–147
  7. Buchsbaum MS, Tang CY, Peled S, Gudbjartsson H, Lu D, Hazlett EA, et al. MRI white matter diffusion anisotropy and PET metabolic rate in schizophrenia. Neuroreport. 1998;9:425–430
  8. Buchsbaum MS, Buchsbaum BR, Hazlett EA, Haznedar MM, Newmark R, Tang CY, et al. Relative glucose metabolic rate higher in white matter in patients with schizophrenia. Am. J. Psychiatry. 2007;164:1072–1081
  9. Byne W, Kidkardnee S, Tatusov A, Yiannoulos G, Buchsbaum MS, Haroutunian V. Schizophrenia-associated reduction of neuronal and oligodendrocyte numbers in the anterior principal thalamic nucleus. Schizophr. Res. 2006;85:245–253
  10. Byne W, Tatusov A, Yiannoulos G, Vong GS, Marcus S. Effects of mental illness and aging in two thalamic nuclei. Schizophr. Res. 2008;106:172–181
  11. Byne W, Hazlett EA, Buchsbaum MS, Kemether E. The thalamus and schizophrenia: current status of research. Acta Neuropathol. 2009;117:347–368
  12. Cahoy JD, Emery B, Kaushal A, Foo LC, Zamanian JL, Christopherson KS, et al. A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J. Neurosci. 2008;28:264–278
  13. Casanova MF. Astrocytosis and schizophrenia. Schizophr. Res. 1991;5:186–187
  14. Cheung V, Cheung C, McAlonan GM, Deng Y, Wong JG, Yip L, et al. A diffusion tensor imaging study of structural dysconnectivity in never-medicated, first-episode schizophrenia. Psychol. Med. 2008;38:877–885
  15. de Vellis J, Carpenter E. Development. In:  Siegel GJ,  Albers RW,  Brady STPDL editor. Basic Neurochemistry. Amsterdam: Elsevier; 2006;p. 437–458
  16. Dracheva S, Davis KL, Chin B, Woo DA, Schmeidler J, Haroutunian V. Myelin-associated mRNA and protein expression deficits in the anterior cingulate cortex and hippocampus in elderly schizophrenia patients. Neurobiol. Dis. 2006;21:531–540
  17. Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD, et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 2001;98:4746–4751
  18. Haroutunian V, Katsel P, Dracheva S, Davis KL. The human homolog of the QKI gene affected in the severe dysmyelination “quaking” mouse phenotype: downregulated in multiple brain regions in schizophrenia. Am. J. Psychiatry. 2006;163:1834–1837
  19. Haroutunian V, Katsel P, Dracheva S, Stewart DG, Davis KL. Variations in oligodendrocyte-related gene expression across multiple cortical regions: implications for the pathophysiology of schizophrenia. Int. J. Neuropsychopharmacol. 2007;10:565–573
  20. Hof PR, Haroutunian V, Friedrich VL, Byne W, Buitron C, Perl DP, et al. Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol. Psychiatry. 2003;53:1075–1085
  21. Kanaan RA, Kim JS, Kaufmann WE, Pearlson GD, Barker GJ, McGuire PK. Diffusion tensor imaging in schizophrenia. Biol. Psychiatry. 2005;58:921–929
  22. Katsel P, Davis KL, Li C, Tan W, Greenstein E, Kleiner Hoffman LB, et al. Abnormal indices of cell cycle activity in schizophrenia and their potential association with oligodendrocytes. Neuropsychopharmacology. 2008;33:2993–3009
  23. Keirstead HS, Blakemore WF. Identification of post-mitotic oligodendrocytes incapable of remyelination within the demyelinated adult spinal cord. J. Neuropathol. Exp. Neurol. 1997;56:1191–1201
  24. Konopaske GT, Dorph-Petersen KA, Sweet RA, Pierri JN, Zhang W, Sampson AR, et al. Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys. Biol. Psychiatry. 2008;63:759–765
  25. Kreczmanski P, Heinsen H, Mantua V, Woltersdorf F, Masson T, Ulfig N, et al. Volume, neuron density and total neuron number in five subcortical regions in schizophrenia. Brain. 2007;130:678–692
  26. Kubicki M, McCarley RW, Shenton ME. Evidence for white matter abnormalities in schizophrenia. Curr. Opin. Psychiatry. 2005;18:121–134
  27. Lasiene J, Sawa Y, Matsui A, Horner PJ. Increased oligodendrogenesis and myelinogenesis in the aging rodent spinal cord. Soc. Neurosci. Abst. 2007;592:11
  28. Lee J, Wu Y, Qi Y, Xue H, Liu Y, Scheel D, et al. Neurogenin3 participates in gliogenesis in the developing vertebrate spinal cord. Dev. Biol. 2003;253:84–98
  29. Loerch PM, Lu T, Dakin KA, Vann JM, Isaacs A, Geula C, et al. Evolution of the aging brain transcriptome and synaptic regulation. PLoS ONE. 2008;3:e3329
  30. Magistretti PJ, Pellerin L. The contribution of astrocytes to the 18F-2-deoxyglucose signal in PET activation studies. Mol. Psychiatry. 1996;1:445–452
  31. Malaspina D, Harkavy-Friedman J, Corcoran C, Mujica-Parodi L, Printz D, Gorman JM, et al. Resting neural activity distinguishes subgroups of schizophrenia patients. Biol. Psychiatry. 2004;56:931–937
  32. McCullumsmith RE, Gupta D, Beneyto M, Kreger E, Haroutunian V, Davis KL, et al. Expression of transcripts for myelination-related genes in the anterior cingulate cortex in schizophrenia. Schizophr. Res. 2007;90:15–27
  33. Mega MS, Cummings JL. Frontal-subcortical circuits and neuropsychiatric disorders. J. Neuropsychiatry Clin. Neurosci. 1994;6:358–370
  34. Mitkus SN, Hyde TM, Vakkalanka R, Kolachana B, Weinberger DR, Kleinman JE, et al. Expression of oligodendrocyte-associated genes in dorsolateral prefrontal cortex of patients with schizophrenia. Schizophr. Res. 2008;98:129–138
  35. Nanitsos EK, Nguyen KT, St'astny F, Balcar VJ. Glutamatergic hypothesis of schizophrenia: involvement of Na+/K+-dependent glutamate transport. J. Biomed. Sci. 2005;12:975–984
  36. Narayan S, Kass KE, Thomas EA. Chronic haloperidol treatment results in a decrease in the expression of myelin/oligodendrocyte-related genes in the mouse brain. J. Neurosci. Res. 2007;85:757–765
  37. Neymeyer V, Tephly TR, Miller MW. Folate and 10-formyltetrahydrofolate dehydrogenase (FDH) expression in the central nervous system of the mature rat. Brain Res. 1997;766:195–204
  38. Nicolay DJ, Doucette JR, Nazarali AJ. Transcriptional control of oligodendrogenesis. Glia. 2007;55:1287–1299
  39. Nishiyama A, Komitova M, Suzuki R, Zhu X. Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity. Nat. Rev., Neurosci. 2009;10:9–22
  40. Olsen ML, Sontheimer H. Functional implications for Kir4.1 channels in glial biology: from K+ buffering to cell differentiation. J. Neurochem. 2008;107:589–601
  41. Osterhout DJ, Wolven A, Wolf RM, Resh MD, Chao MV. Morphological differentiation of oligodendrocytes requires activation of Fyn tyrosine kinase. J. Cell Biol. 1999;145:1209–1218
  42. Paez PM, Garcia CI, Soto EF, Pasquini JM. Apotransferrin decreases the response of oligodendrocyte progenitors to PDGF and inhibits the progression of the cell cycle. Neurochem. Int. 2006;49:359–371
  43. Peters A. The effects of normal aging on myelin and nerve fibers: a review. J. Neurocytol. 2002;31:581–593
  44. Peters A, Sethares C. Oligodendrocytes, their progenitors and other neuroglial cells in the aging primate cerebral cortex. Cereb. Cortex. 2004;14:995–1007
  45. Shi J, Marinovich A, Barres BA. Purification and characterization of adult oligodendrocyte precursor cells from the rat optic nerve. J. Neurosci. 1998;18:4627–4636
  46. Smith RE, Haroutunian V, Davis KL, Meador-Woodruff JH. Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia. Am. J. Psychiatry. 2001;158:1393–1399
  47. Steiner J, Bernstein HG, Bielau H, Farkas N, Winter J, Dobrowolny H, et al. S100B-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: a morphometric study. J. Psychiatr. Res. 2008;42:868–876
  48. Swanson LW, Cowan WM. An autoradiographic study of the organization of the efferent connections of the hippocampal formation in the rat. J. Comp. Neurol. 1977;172:49–84
  49. Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB, et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet. 2003;362:798–805
  50. Torrey EF, Webster M, Knable M, Johnston N, Yolken RH. The Stanley Foundation brain collection and neuropathology consortium. Schizophr. Res. 2000;44:151–155
  51. Uranova N, Orlovskaya D, Vikhreva O, Zimina I, Kolomeets N, Vostrikov V, et al. Electron microscopy of oligodendroglia in severe mental illness. Brain Res. Bull. 2001;55:597–610
  52. Uranova NA, Vostrikov VM, Orlovskaya DD, Rachmanova VI. Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr. Res. 2004;67:269–275
  53. van Beveren NJ, van der Spelt JJ, de Haan L, Fekkes D. Schizophrenia-associated neural growth factors in peripheral blood. A review. Eur. Neuropsychopharmacol. 2006;16:469–480
  54. van Groen T, Kadish I, Wyss JM. Efferent connections of the anteromedial nucleus of the thalamus of the rat. Brain Res. Brain Res. Rev. 1999;30:1–26
  55. Vogt BA, Pandya DN, Rosene DL. Cingulate cortex of the rhesus monkey: I. Cytoarchitecture and thalamic afferents. J. Comp. Neurol. 1987;262:256–270
  56. Wegner M. Expression of transcription factors during oligodendroglial development. Microsc. Res. Tech. 2001;52:746–752
  57. Weis S, Llenos IC. GFAP-immunopositive astrocytes in schizophrenia. Schizophr. Res. 2004;67:293–295
  58. Xiao L, Xu H, Zhang Y, Wei Z, He J, Jiang W, et al. Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changes. Mol. Psychiatry. 2008;13:697–708
  59. Yoshihara Y, Sugihara G, Matsumoto H, Suckling J, Nishimura K, Toyoda T, et al. Voxel-based structural magnetic resonance imaging (MRI) study of patients with early onset schizophrenia. Ann. Gen. Psychiatry. 2008;7:25
  60. Young KA, Manaye KF, Liang CL, Hicks PB, German DC. Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia. Biol. Psychiatry. 2000;47:944–953
  61. Zhu X, Hill RA, Nishiyama A. NG2 cells generate oligodendrocytes and gray matter astrocytes in the spinal cord. Neuron Glia Biol. 2008;1–8

PII: S0920-9964(09)00176-5

doi: 10.1016/j.schres.2009.04.019

Schizophrenia Research
Volume 112, Issue 1 , Pages 54-64 , July 2009

Article Tools

* Image Usage & Resolution